Search

everythinglearnresearchcommunity

for

Search:↓

Nutrient antioxidants helped reduce prednisolone dosage and improved hair growth in alopecia areata patients.

Higher IL-17A levels indicate more severe alopecia areata.

Melatonin may help reduce the needed dose of prednisolone and improve hair growth in alopecia areata patients.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

A woman with severe hair loss due to systemic sclerosis regrew her hair in 4 months using a combination of treatments.

Dermoscopy is useful for diagnosing different types of hair loss.

COVID-19 reinfection may trigger alopecia areata.

Familial frontal fibrosing alopecia is rare, mostly affects women, and often occurs between sisters or mother-daughter pairs.

Linagliptin may cause hair loss and skin blisters.

Apremilast shows promise for several skin conditions but needs more research.

Pseudopelade of Brocq is hard to diagnose and treat, with limited effective options.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Illness perception affects mental health and quality of life in Chinese alopecia patients.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

The document says homoeopathic treatments are good for hair regrowth in alopecia areata but doesn't give proof.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Alopecia areata treatment varies, with no optimal method established yet.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

A kidney transplant patient on cyclosporin experienced unexpected severe hair loss, which improved with treatment adjustments.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

A man with a birthmark on his scalp developed hair loss that improved with treatment, but the link between the birthmark and hair loss was unclear.